Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001567619-23-006677
Filing Date
2023-07-26
Accepted
2023-07-26 11:50:07
Documents
1
Effectiveness Date
2023-07-26
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9248
  Complete submission text file 0001567619-23-006677.txt   10698
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-487908 | Film No.: 231111514
SIC: 2834 Pharmaceutical Preparations